Search research articles
Contact Us
Filters
Showing results (21-30 of 117) with videos related to
Page
of 12
Sort By:
Organic Letters
|
October 9, 2007
Nitric oxide prodrugs: diazeniumdiolate anions of hindered secondary amines
Harinath Chakrapani, Brett M Showalter, Michael L Citro, et al.
Organic Letters
|
October 30, 2008
Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs
Harinath Chakrapani, Anna E Maciag, Michael L Citro, et al.
Bioorganic & Medicinal Chemistry
|
February 24, 2012
Diazeniumdiolated carbamates: a novel class of nitric oxide donors
Rahul S Nandurdikar, Anna E Maciag, Zhao Cao, et al.
The Journal of Organic Chemistry
|
July 9, 2021
Piperazine as a Linker for Incorporating the Nitric Oxide-Releasing Diazeniumdiolate Group into Other Biomedically Relevant Functional Molecules
Joseph E Saavedra, Melissa N Booth, Joseph A Hrabie, et al.
Cancer Letters
|
July 31, 2007
The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis
Wei Qu, Jie Liu, Richard Fuquay, et al.
Journal of Medicinal Chemistry
|
March 5, 2008
Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies
Carlos A Velázquez, Qiao-Hong Chen, Michael L Citro, et al.
Nitric Oxide : Biology and Chemistry
|
October 16, 2013
Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase
Ryan J Holland, Rika Paulisch, Zhao Cao, et al.
Cancer Science
|
January 22, 2009
V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity
Wei Qu, Jie Liu, Anna L Dill, et al.
Journal of Medicinal Chemistry
|
December 5, 2008
Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities
Daniela Andrei, Anna E Maciag, Harinath Chakrapani, et al.
Molecular Cancer Therapeutics
|
January 7, 2004
Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Arindam Dhar, June M Brindley, Cristi Stark, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 117) with videos related to
Sort By:
Page
of 12
Organic Letters
|
October 9, 2007
Nitric oxide prodrugs: diazeniumdiolate anions of hindered secondary amines
Harinath Chakrapani, Brett M Showalter, Michael L Citro, et al.
Organic Letters
|
October 30, 2008
Cell-permeable esters of diazeniumdiolate-based nitric oxide prodrugs
Harinath Chakrapani, Anna E Maciag, Michael L Citro, et al.
Bioorganic & Medicinal Chemistry
|
February 24, 2012
Diazeniumdiolated carbamates: a novel class of nitric oxide donors
Rahul S Nandurdikar, Anna E Maciag, Zhao Cao, et al.
The Journal of Organic Chemistry
|
July 9, 2021
Piperazine as a Linker for Incorporating the Nitric Oxide-Releasing Diazeniumdiolate Group into Other Biomedically Relevant Functional Molecules
Joseph E Saavedra, Melissa N Booth, Joseph A Hrabie, et al.
Cancer Letters
|
July 31, 2007
The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis
Wei Qu, Jie Liu, Richard Fuquay, et al.
Journal of Medicinal Chemistry
|
March 5, 2008
Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies
Carlos A Velázquez, Qiao-Hong Chen, Michael L Citro, et al.
Nitric Oxide : Biology and Chemistry
|
October 16, 2013
Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase
Ryan J Holland, Rika Paulisch, Zhao Cao, et al.
Cancer Science
|
January 22, 2009
V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity
Wei Qu, Jie Liu, Anna L Dill, et al.
Journal of Medicinal Chemistry
|
December 5, 2008
Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities
Daniela Andrei, Anna E Maciag, Harinath Chakrapani, et al.
Molecular Cancer Therapeutics
|
January 7, 2004
Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Arindam Dhar, June M Brindley, Cristi Stark, et al.
Page
of 12